PT  - JOURNAL ARTICLE
AU  - Schwarze, Julia Katharina
AU  - Tijtgat, Jens
AU  - Awada, Gil
AU  - Cras, Louise
AU  - Vasaturo, Angela
AU  - Bagnall, Christopher
AU  - Forsyth, Ramses
AU  - Dufait, Inès
AU  - Tuyaerts, Sandra
AU  - Van Riet, Ivan
AU  - Neyns, Bart
TI  - Intratumoral administration of CD1c (BDCA-1)<sup>+</sup> and CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial
AID  - 10.1136/jitc-2022-005141
DP  - 2022 Sep 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e005141
VI  - 10
IP  - 9
4099  - http://jitc.bmj.com/content/10/9/e005141.short
4100  - http://jitc.bmj.com/content/10/9/e005141.full
SO  - J Immunother Cancer2022 Sep 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.